Many inhibitory and toxic effects show a dose dependence for which the extrapolation of a linear plot to zero or background effect cuts through the abscissa at some positive dose, indicating a threshold concentration below which the agent seems to be ineffective (1) . If the teratogenic effect of such an agent is caused by the same cellular reaction, its dose-effect curve may also exhibit a threshold, though with a lower value. In contrast, for most mutagenic compounds a linear plot of the frequency of induced mutations against the dose (concentration) has exhibited no threshold; such experiments were done with transforming DNA or bacterial viruses (2) (3) (4) , bacteria or fungi (5, 6) , plants (7) (8) (9) , Sparrow and Scheirer, personal communication), insects (10) , and mammalian test systems (11, 12 ). An apparent threshold of mutation induction has been observed only rarely, usually where the investigated cells could be reached only after the mutagen had passed several barriers (12, 13) . One may therefore ask whether there are fundamental reasons for this different dose response of toxic versus mutagenic effects and under which conditions a threshold effect could be expected. Such considerations are important for the experimental evaluation of the potential hazard of pesticides, drugs, or food additives. Before this problem is examined, a few words are needed concerning the extrapolation of experimental data. Such data can always be plotted in a number of ways, e.g., linearly against the dose, against some power of the dose, or against the logarithm of the dose (as is usually done for toxic compounds with very different potencies). To demonstrate its increase with some power of the dose, one can also plot the logarithm of the effect against the logarithm of the dose. While any of these plots can be used to display experimental points, an extrapolation of such points to lower dose values is justified only if there are good theoretical reasons to assume a particular dose dependence (linear, square, etc.). In many experimental systems, especially in simple microbial tests, there are good chemical reasons to assume that the effect at low doses increases linearly with (or with the square of) the dose, and the experimental data have verified this assumption wherever it was tested extensively (2, 3); a straightline extrapolation of a linear plot (or a plot against the square of the dose) is then justified. However, if no such assumptions are warranted, the following approach seems the only one justified. After making as many measurements as feasible, one calculates for various possible dose-effect curves (e.g., polynomials with unknown coefficients and exponents), the best least-square approximation of all the experimental points (with different weights if warranted), and the mean-square deviation from the calculated curve (such calculations are simple and fast if modern computer programs are used). At this stage, one can either assume that the curve with the lowest mean-square deviation represents the correct curve, or one can still insert a theoretical bias to select out of several curves -with similar mean-square deviations the-.on. which appears most likely correct.--Although this approach is not as precise as. obtaining more data, it certainly is more satisfactory than the guesses often used in the interpretation of experimental data. A thorough statistical evaluation of such data is the-more valuable the more complex the biological system, because the time needed for analysis represents a progressively smaller fraction of the time needed to acquire additional data at lower dose levels. Unfortunately, experimental data are often too sparse to allow any statistical curve fitting.
Toxic Effects
Most toxic compounds or other agents in commercial or medical use inhibit cellular reactions reversibly, some inhibit irreversibly, and few kill individual cells.
Reversible inhibition may affect, e.g., an enzyme or the transport mechanism of the cell. It is subject to the mass action laws summarized by the Michaelis-Menton equation (1 ) .
If the inhibited reaction is rate-limiting, the extent of inhibition I is described by: (2) Zero inhibition is obtained when c = T. The curves described by eq, (2) are the same as for eq, (1), except that they are shifted along the abscissa by the value T (if K = k-T).
For slowly reversible or irreversible inhibition the situation is similar, but the equations become more complex and in the case of irreversible inhibitors cannot be explained by the Michaelis-Menton theory (1 Similarly, a small number of killed cells, which does not limit the function of an organ, may already be disastrous for development. The threshold (if any) for teratogenic effects is presumably lower, therefore, than that for toxic effects.
Mutagenic Effect
A mutation can be induced by the reaction of one or two reagent molecules with DNA. Such reactions can produce base pair changes that lead to point mutations and alter the functional properties of single genes, or they can produce large chromosome alterations that affect several genes or even whole chromosome segments. Mutagenic effects are more insidious than toxic effects, for a single mutated cell that multiplies can produce a massive effect in an organism. In comparison, the death of a single cell is relatively harmless, except when it occurs during early embryogenesis. If the mutation affects a germinal cell, a dominant or recessive hereditary disease or loss of vitality may arise in the offspring; if it alters an embryonic cell a malformation may ensue; if it affects an adult cell, a tumor or leukemia may develop (15) .
Most direct mutagens react covalently with DNA, are incorporated into DNA, or bind quasi-irreversibly to DNA or its synthase. All these reactions have been found to increase linearly with the concentration of the compound. There is apparently no intracellular process by which a mutation can be eliminated from a cell, once it has been finalized in both strands of the doublestranded DNA molecule.
If the mutated cell has an altered surface, it can be recognized as a strange body and be removed by phagocytosis or be coated by circulating antibodies; such surface recognition may in fact provide the major protection of higher organisms against a high incidence of malignant growth (16) . Without such surface changes, however, the mutated cell can persist, and even with such changes a fraction of mutated cells apparently can occasionally replicate beyond the stage at which antibodies or other cellular reactions can arrest further growth. In normal animals, more than one DNA alteration per cell may be required to cause some types of cancer, because the production of pulmonary tumors in mice increased approximately with the square of the concentration of different alkylating chemicals (17) . The possibility that multiple mutations are required for cancer had earlier been proposed by Ashley (18) . A statistical analysis of retinoblastomas in humans also indicated that two separate events (mutations) are needed for the occurrence of most monolateral cases; however, only one such event is required for bilateral cases, the other mutation apparently being inherited (19) . Also, radiation-induced leukemia and tumors increased linearly with the dose (20) . In any case, neither for radiation nor for carcinogens that can react directly with DNA has the dose dependence indicated the presence of a threshold (17, 20, 21) .
Nevertheless, an apparent or a true threshold of mutation (or cancer) induction can be expected to occur for a variety of reasons. The frequency of such genetic effects in different tissues is affected by the rates of distribution, absorption, metabolism, and excretion of the mutagen, each of which can be influenced by genetic and environmental factors. For example, an apparent threshold concentration could be expected either if the mutagen would be very effectively destroyed before it could reach the nucleus (e.g., peroxides and other radical-producing compounds are destroyed by peroxidase or catalase) or if it would bind to, be taken up by, or otherwise react with the cells close to the site of administration, so that it could not reach the germinal cells whose mutation alone would be measured in certain tests. Only rather high concentrations of a compound might then show a strong mutagenic effect.
As another possibility, the activation or destruction of the mutagen may require enzyme reactions that can be induced either by the mutagen itself or by some other compound. Since the importance of such enzyme reactions (often microsomal enzymes) has been realized, the correlation between mutagens and carcinogens has steadily increased (15, 22, 23 
Conclusion
If one wants to protect mankind adequately against mutations, one should extrapolate mutagenic or carcinogenic effects, observed at high doses of a compound, either linearly or with some exponent of the concentration, if that can be established at high doses (concentrations), to the spontaneous background effect of zero dose, unless statistically significant measurements or knowledge of the mutagenic mechanisms warrant otherwise. There is certainly no justification to assume a positive no-effect (background only) dose for any mutagen or carcinogen, except when the molecular mechanism by which the particular compound induces mutations renders such a threshold effect likely (e.g., if the mutations are produced by enzyme inhibition). Such a postulate is necessary, because mutagenic or carcinogenic tests in mammals are expensive and time-consuming, so that it is not feasible to examine the mutagenic effect of many compounds down to the low concentrations to which mankind is exposed. It is also needed as a minimum safety valve, because the genetic and nutritional variation of people and the influence of other environmental compounds that act as activators or reducers of a mutagenic effect can greatly influence the mutagenicity or carcinogenicity of a given compound. Society may decide that the benefit of some compounds warrants a small risk whose level can be set at a certain value, as was done for x-radiation (20) . Those who then still advocate the widespread use of a compound at a dose exceeding the accepted risk level, because they claim the existence of a threshold dose below which the compound might be genetically ineffective, should be obliged to prove their contention by statistically significant measurements of the genetic effects of the compound at the proposed human dose in all usually employed mammalian test systems.
Discussion
Dr. R. B. Cummings (ORNL): I'd like to make a comment about EMS reaching the target; it does reach the target. If one looks at the ethylation of DNA in sperm cells plotted against the administered dose interperitoneally, the effect is linear with dose in a range from 400 to 50 mg/kg, and at 5 mg/kg it is only slightly off that linear extrapolation downward. If one looks at ethylations/nucleotide DNA extracted from the whole testes after the DNA is cleaned up on a cesium chloride gradient, again the ethylations per nucleotide follow a more complex function but they follow it from a very high dose down to 5 mg/kg. I don't really understand the kinetics of that, but the point is that there is no break in the effect; it gets in at high doses and low doses, the function is smoothly continuous. 
affected, by inhibition or cell killing before significant toxicity is observed.
Dr. Kensler: One of the primary missions of the NCTR was to set up a megamouse experiment to try to tell the shape of the dose curve. Most people said this would be a waste of time and money. Dr. Freese: I'm not saying that one should do it, but because it can't be done one has to extrapolate. One should not extrapolate to some assumed no-effect value, but one should extrapolate linearly down to zero dose.
Dr. Kensler: In our current status of ignorance I'd like to see us investigate the lower end of the dose curve, particularly for different kinds of chemical mutagens.
Dr. Cummings: One more point with regard to the Generoso data. I think that the data do not say that there is a threshold. The data with regard to dominant lethals simply say that you reach a point at which it can no longer be measured. That's a different thing; in fact, there is a positive effect with regard to translocation at the lowest dose measured. It would probably be possible to measure a translocation frequency at even lower doses by doing a larger experiment. The data really agree with your interpretation.
Dr. Freese: Some of these issues are semantic. The question is how you want to extrapolate the data. You may decide that you want to extrapolate the experimental curve down to that dose which will give you a no-effect point or you may decide to take the lowest experimental value and extrapolate it linearly down to zero concentration, which will give some effect at any dose.
Dr. Cummings: Right. I don't know of any data that would suggest that there is a real threshold.
Dr can see the toxicologist point of view-that the substance may not reach the target organ. It seems to me that we have a real problem here, in that many environmental mutagens, two that I've worked with, both mopped up pretty strongly in the body. The concentration gradient from the route of entry to the gonads can be very steep-so steep that I doubt whether the pharmacologists can measure itand this makes it exceedingly difficult to do any calculations. The toxicologists may believe firmly Dr. Freese: I think what we are trying to do is that there is no mutagen in the gonads, and they to put the burden of proof upon those who argue may be right. Certainly it will be quite clear that that there may be a threshold. Environmental Health Perspectives
